Stabilization of Clinical Samples Collected for Quantitative Bioanalysis – A Reflection from The European Bioanalysis Forum

References

• Van de Merbel N , de VriesR. Aging of biological matrices and its effect on bioanalytical method performance. Bioanalysis5 (19), 2393–2407 (2013).
   PubMed Web of Science ®Google Scholar
• Briscoe CJ , HageDS. Factors affecting the stability of drugs and drug metabolites in biological matrices. Bioanalysis1 (1), 205–220 (2009).
   PubMed Web of Science ®Google Scholar
• Ohnmacht CM . LC–MS bioanalysis of photosensitive and oxidatively labile compound. In : Handbook Of LC–MS Bioanalysis, Best Practices Experimental Protocols and Regulations. John Wiley and Sons, Inc, NY, USA, 491–504 (2013).
   Google Scholar
• Peters FT . Stability of analytes in biosamples- an important issue in clinical and forensic toxicology?Anal. Bioanal. Chem. 388 (7), 1505–1519 (2007).
   PubMed Web of Science ®Google Scholar
• Ji AJ , JiangZ, LivsonY, DavisJA, ChuJX, WengN. Challenges in urine bioanalytical assays: overcoming non specific binding. Bioanalysis2 (9), 1573–1586 (2010).
   PubMed Web of Science ®Google Scholar
• Li W , ZhangJ, TseFL. Strategies in quantitative LC–MS/MS analysis of unstable small molecules in bioanalytical matrixes. Biomed. Chromatogr. 25 (1–2), 258–277 (2011).
   PubMed Web of Science ®Google Scholar
• Chen J , HsiehY. Stabilizing drug molecules in biological samples. Ther. Drug Monit. 27 (5), 617–624 (2005).
   PubMed Web of Science ®Google Scholar
• Van der Merbel N , SavoieN, YadavMet al. Stability: recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization team. AAPS J. 16 (3), 392–399 (2014).
   PubMed Web of Science ®Google Scholar
• Heinig K . What are the challenges of stability investigations and sample stabilization in regulated bioanalysis. Bioanalysis5 (15), 1811–1814 (2013).
   PubMed Web of Science ®Google Scholar
• Sennbro CJ , KnutssonM, van AmsterdamP, TimmermanP. Anticoagulant counter ion impact on bioanalytical LC–MS/MS assays: results from discussions and experiments within the European Bioanalytical Forum. Bioanalysis3 (21), 2393–2399 (2011).
   PubMed Web of Science ®Google Scholar
• Japanese Ministry of Health, Welfare and Labour . Guideline on Bioanalytical Method Validation in Pharmaceutical Development (2013).
   Google Scholar
• Brazilian Agência de Nacional de Vigilância Sanitária . Resolution- RDC Nº 27, Requirements for the validation of bioanalytical methods (2012). http://bcn2012.europeanbioanalysisforum.eu/slides/day%203/7%20updates%20from%20the%20globe/3_tavares.pdf.
   Google Scholar
• US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine . Guidance for Industry: Bioanalytical Method Validation. (2001). www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf.
   Google Scholar
• US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine . Guidance for Industry: Bioanalytical Method Validation. Draft Guidance. September 2013.
   Google Scholar
• European Medicines Agency, Committee for Medicinal Products for Human Use . Guideline on bioanalytical method validation. (2011). www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
   Google Scholar
• Boterman M , DOIGm, BredaMet al. Recommendations on the interpretation of the new European medicines agency guideline on bioanalytical method validation by global CRO council for bioanalysis (GCC). Bioanalysis4 (6), 651–660 (2012).
   PubMed Web of Science ®Google Scholar
• Lowes S , JerseyJ, ShoupRet al. Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the global CRO council for bioanalysis. Bioanalysis3 (12), 1223–1332 (2011).
   Web of Science ®Google Scholar
• van Amsterdam P , CompanjenA, Brudny-KloeppelM, GolobM, LuedtkeS, TimmermanP. The European Bioanalysis forum community’s evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method validation. Bioanalysis5 (6), 645–659 (2013).
   PubMed Web of Science ®Google Scholar
• Freisleben A , Brudny-KlöppelM, MulderH, de VriesR, de ZwartM, TimmermanP. Blood stability testing: European Bioanalysis Forum view on current challenges for regulated bioanalysis. Bioanalysis3 (12), 1333–1336 (2011).
   PubMed Web of Science ®Google Scholar
• Viswanathan CT , BasalS, BoothBet al. Workshop/Conference Report-Quantitave bioanakytical methods validation and implementation: best practices for chromatographic and ligand binding assay. AAPS J9, E30–E42 (2007).
   Web of Science ®Google Scholar
• Timmerman P . Tiered approach revisited: introducing stage-approach or assay-appropriate scientific validation. Bioanalysis6 (5), 599–604 (2014).
   PubMed Web of Science ®Google Scholar
• Timmerman P , WhiteS, KnutssonMet al. Feedback from the EBF workshop: taking tiered approach to the next level. Bioanalysis6 (19), 2593–2598 (2014).
   PubMed Web of Science ®Google Scholar
• Hilhorst MJ , HendriksG, Van HoutMW, SillenH, van de MerbelNC. HPLC–MS/MS method for the determination of cytarabine in human plasma. Bioanalysis3 (14), 1603–1611 (2011).
   PubMed Web of Science ®Google Scholar
• Fung EN , ZhengN, ArnoldMEet al. Effective screening approach to select esterase inhibitors used for stabilizing ester containing prodrugs analyzed by LC–MS/MS. Bioanalysis2 (4), 733–743 (2010).
   PubMed Web of Science ®Google Scholar
• Du L , MussonDG. Stability studies of vorinostat and its two metabolites in human plasma serum and urine. J. Pharm. Biomed. Anal. 42 (5), 556–564 (2006).
   PubMed Web of Science ®Google Scholar
• Gruenke LD , CraigJC, KleinFDet al. Determination of chlorpromazine and its major metabolites by gas chromatography/mass spectrometry: application to biological fluids. Biomed. Mass Spectrom. 12 (12), 707–713 (1985).
   PubMedGoogle Scholar
• Suchocka Z , SwatowskaJ, PacheckaJ, SuchockiP. Determination of paraoxonase 3 activity in human blood serum. J. Pharm. Biomed. Anal. 42 (1), 113–119 (2006).
   PubMed Web of Science ®Google Scholar
• Bieri JG , EvartsRP, ThorpeS. Factors affecting the exchange of tocopherol between red blood cells and plasma. Am. J. Clin. Nutr. 30, 686–690 (1977).
   PubMed Web of Science ®Google Scholar
• Lentjes EG , RomijnFH. Temperature dependent cortisol distribution among blood compartments in man. J. Clin. Endocrinol. Metab. 84, 682–687 (1999).
   PubMed Web of Science ®Google Scholar
• Atkinson K , BrittonK, BiggsJ. Distribution and concentration of cyclosporine in human blood. J. Clin. Pathol. 37, 1167–1171 (1984).
   PubMed Web of Science ®Google Scholar
• Fišar Z , FuksováK, SikoraJet al. Distribution of antidepressants between plasma and red blood cells. Neuroendocrinol. Lert. 27, 307–313 (2006).
   PubMed Web of Science ®Google Scholar
• Arrhenius S . Ueber die Reaktionsgeschwindigkeit bei der Inversion von Rohrzucker durch Säuren. Z. Phys. Chem. 4, 226–248 (1889).
   Google Scholar
• Arrhenius S . “Zur Theorie der chemischen Reaktionsgeschwindigkeit,” in Bihang, 24, no.2 (1898). Z. phys. Chem. 28, 317–335 (1899).
   Google Scholar
• Aranov PA , HallLM, DettmerK, StephensenCB, HammockBD. Metabolic profiling of major vitamin D metabolites using Diels Alder derivatisation and ultra-performance-liquid – chromatogrpahy tandem mass spectrometry. Anal. Bioanal. Chem. 391, 1917–1930 (2008).
   PubMed Web of Science ®Google Scholar
• Anderson A , EhrssonH. Stability of cisplatin and its monohydrated complex in blood, plasma and ultrafiltrate. J. Pharm. Biomed. Anal. 13, 639–644 (1995).
   PubMed Web of Science ®Google Scholar
• Fura A , HarperTW, ZhangH, FungL, ShyuWC. Shift in pH of biological fluids during storage and processing: effect on bioanalysis. J. Pharm. Biomed. Anal. 32, 513–522 (2003).
   PubMed Web of Science ®Google Scholar
• Van de Merbel N , de VriesR. Age of biological matrices and its effect on bioanalytical method performance. Bioanalysis5 (19), 2393–2407 (2013).
   PubMed Web of Science ®Google Scholar
• T. Ebner T , HeinzelG, ProxA, Beschke, WachsmuthH. Disposition and chemical stability of telmisartan 1-o-acylglucuronide. Drug Metab. Dispos. 27 (10), 1143–1149 (1999).
   PubMed Web of Science ®Google Scholar
• Dell D . Labile metabolites. Chromatographia59, S139–S148 (2004).
   Web of Science ®Google Scholar
• Van de Merbel , HendriksG, ImbosR, TuunainenJ, RouruJ, NikkanenH. Quantitative determination of free and total dopamine in human plasma by LC–MS/MS: the importance of sample preparation. Bioanalysis3 (17), 1949–1961 (2011).
   PubMed Web of Science ®Google Scholar
• Van de Merbel NC , BronsemaKJ, van HoutMW, NilssonR, SillenH. A validated liquid chromatograqphy-tandem mass spectrometry method for the quantitative determination of 4β-hydroxycholesterole in human plasma. J. Pharm. Biomed. Anal. 55 (5), 1089–1095 (2011).
   PubMed Web of Science ®Google Scholar
• Wang G , HsiehY, LauYet al. Semi-automated determination of plasma stability of drug discovery compounds using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 780 (2), 451–457 (2002).
   PubMed Web of Science ®Google Scholar
• Lindegardh N , DaviesGR, HienTTet al. Importance of collection tube during clinical studies of oseltamivir. Antimicrob. Agents Chemother. 51 (5), 1835–1836 (2007).
   PubMed Web of Science ®Google Scholar
• Pham-huy C , Villain-PautetG, HuaHet al. Seperation of oxazepam. Lorazepam and temazepam enantiomers by HPLC on a derivatized cyclodextrin-bonded phase: application to the determination of oxazepam in plasma. J. Biochem. Biophys. Meth54, 287–299 (2002).
   PubMedGoogle Scholar
• Zhao Y , SukbunthernqJ, AntonianL. Simultanious determination of Z-Su5416 and its interconvertible geometric E-isomer in rat plasma by LC/MS/MS. J. Pharm. Biomed. Anal. 35 (3), 513–522 (2004).
   PubMed Web of Science ®Google Scholar
• Yan KX , SongH, LoMW. Determination of MK-0767 enantiomers in human plasma by normal phase LC–MS/MS. J. Chromatogr. B813, 95–102 (2004).
   PubMed Web of Science ®Google Scholar
• Wang CJ , paoLH, HsiongCH, WuCY, Whang-PengJJ, HuOYP. Novel inhibition of cis/trans retinoic acid interconversion in biological fluids – an accurate method for the determination of trans and 13-cis retinoic acid in biological fluids. J. Chromatogr. B. 796 (2), 283–291 (2003).
   PubMed Web of Science ®Google Scholar
• Jemal M , KhanS, TeitzDS, McCaffertyJA, HawthorneDJ. LC/MS/MS determination ofomapatrilat, a sulfhydryl-containing vasopeptidase inhibitor, and its sulfhydryl- and thioether-containing metabolites in human plasma. Anal. Chem, 73, 5450–5456 (2001).
   PubMed Web of Science ®Google Scholar
• Abu-Shandi KH , RedelE. Quantification and stability evaluation of the highly specific angiotensin-converting enzyme (ACE) inhibitor Captopril in human plasma using a gas chromatography method woth N,N,N’,N’-tetramethyl-2-butenediamide derivatisation agent. Jordan J. Chem. 4, 189–194 (2009).
   Google Scholar
• Ji AJ . LC–MS bioanalysis of drugs in urine. In : Handbook of LC–MS Bioanalysis, best practices experimental protocols and regulations. John Wiley and Sons, Inc, NY, USA, 307–316 (2013).
   Google Scholar
• Vainchtein LD , RosingH, MirejovskyD, LenazL, SchellensJHM, BeijnenJH. Stability experiments in human urine with E09 (apaziquone): a novel anticancer agent for the intravesical treatment of bladder cancer. J. Pharm. Biomed. Anal. 43 (1), 285–292 (2007).
   PubMed Web of Science ®Google Scholar